Ning Hua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ning Hua has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Lee E. Goldstein
Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA
4 shared publications - Olga Minaeva
Boston University Chobanian & Avedisian School of Medicine, Boston, MA USA
3 shared publications - Ali Guermazi
Department of Radiology, Boston University School of Medicine, Boston, Mass
2 shared publications Erich S. Franz
2 shared publications- Hernan Jara
Department of Radiology, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
2 shared publications - Jorge A. Soto
Boston University Medical Center
2 shared publications
Latest Publications
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
MRI Markers for Detecting Accelerated Alzheimer’s Disease after Neurotrauma
Background: A history of traumatic brain injury (TBI) is linked to an earlier onset of Alzheimer’s disease (AD) (Nemetz et al., 1999). Evidence showed that the more severe the injury, the greater risk of developing AD (Johnson et al.,2010). However, systematic evaluation of in vivo MRI markers in the monitoring of AD progression after trauma is lacking. Here, we investigated the performance of various MRI markers in tracking AD progression after neurotrauma in a mouse model of AD. The following MRI sequences were investigated: dynamic contrast‐enhanced (DCE) MRI, Fluid attenuated inversion recovery (FLAIR) MRI, Quantitative Susceptibility Mapping (QSM) and diffusion MRI.Method: 3xTg‐AD mice (Jackson Laboratory, ME) were bred and maintained at Boston University. Unanesthetized mice were pretreated with a non‐sedating dose of the analgesic buprenorphine (0.2mg/kg, i.p.) prior to TBI. Male and female 3xTg‐AD mice were subjected to left‐lateral closed‐head impact injury at 10‐12 weeks of age as described in our previous work (Tagge et al., 2018). MRI data were acquired at 1 day, 3 days, 1 month and 3 months post TBI. DCE‐MRI was analyzed using in‐house software programmed in Matlab (Mathworks, MA). The volume of white matter hyperintensity was measured using manual contours in ImageJ (NIH). QSM data was analyzed using JHU/KKI QSM Toolbox (Li et al, 2019). Diffusion MRS was analyzed in DSI Studio (http://dsistudio.labsolver.org). Age, gender matched 3xTg‐AD mice without TBI were used as controls.Result: Increased blood‐brain permeability was detected by DCE‐MRI and changes of white matter susceptibility detected by QSM were observed in the subacute phase (1‐3 days) post TBI. Accelerated development of white matter hyperintensity was observed as early as 1 month post TBI.Conclusion: MRI markers provide valuable measures of the integrities of blood‐brain barrier and white matter after neurotrauma in vivo, and have the potential to facilitate the management of neurotrauma subjects with a risk of accelerated AD development.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessMRI Markers for Detecting Accelerated Alzheimer’s Disease after Neurotrauma
Background: A history of traumatic brain injury (TBI) is linked to an earlier onset of Alzheimer’s disease (AD) (Nemetz et al., 1999). Evidence showed that the more severe the injury, the greater risk of developing AD (Johnson et al.,2010). However, systematic evaluation of in vivo MRI markers in the monitoring of AD progression after trauma is lacking. Here, we investigated the performance of various MRI markers in tracking AD progression after neurotrauma in a mouse model of AD. The following MRI sequences were investigated: dynamic contrast‐enhanced (DCE) MRI, Fluid attenuated inversion recovery (FLAIR) MRI, Quantitative Susceptibility Mapping (QSM) and diffusion MRI.Method: 3xTg‐AD mice (Jackson Laboratory, ME) were bred and maintained at Boston University. Unanesthetized mice were pretreated with a non‐sedating dose of the analgesic buprenorphine (0.2mg/kg, i.p.) prior to TBI. Male and female 3xTg‐AD mice were subjected to left‐lateral closed‐head impact injury at 10‐12 weeks of age as described in our previous work (Tagge et al., 2018). MRI data were acquired at 1 day, 3 days, 1 month and 3 months post TBI. DCE‐MRI was analyzed using in‐house software programmed in Matlab (Mathworks, MA). The volume of white matter hyperintensity was measured using manual contours in ImageJ (NIH). QSM data was analyzed using JHU/KKI QSM Toolbox (Li et al, 2019). Diffusion MRS was analyzed in DSI Studio (http://dsistudio.labsolver.org). Age, gender matched 3xTg‐AD mice without TBI were used as controls.Result: Increased blood‐brain permeability was detected by DCE‐MRI and changes of white matter susceptibility detected by QSM were observed in the subacute phase (1‐3 days) post TBI. Accelerated development of white matter hyperintensity was observed as early as 1 month post TBI.Conclusion: MRI markers provide valuable measures of the integrities of blood‐brain barrier and white matter after neurotrauma in vivo, and have the potential to facilitate the management of neurotrauma subjects with a risk of accelerated AD development.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Molecular activation of gliovascular signaling precedes blood‐brain barrier disruption and neuronal loss in a mouse model of tauopathy
Background: Increasing evidence points to disruption of the blood‐brain barrier (BBB) as an inciting event in the pathogenesis of Alzheimer’s disease. The contribution of tau‐mediated pathways driving blood‐brain dysfunction are comparatively understudied.Method: Using the P301S mouse model of tauopathy, we employed dynamic contrast enhanced MRI (DCE‐MRI) and quantitative spatial analysis using gadolinium‐based mass spectrometry imaging to demonstrate widespread BBB dysfunction in late stage tauopathy. To identify molecular pathways regulating intercellular signaling between neurons and gliovascular support cells that are dysregulated in advance of BBB disruption, we developed a cell‐specific viral approach for transcriptional profiling of novel pathways within the multicellular environment of the neurovascular unit (NVU) in tauopathy. Viral constructs using cell‐type specific promoters (hSynapsin, GFAP, or PDGFRb) to drive expression of antigen‐tagged ribosomes (TRAP) were used to study variance in spatial and temporal gene expression patterns in NVU cell types in P301S transgenic mice prior to widespread BBB disruption.Result: Regional disruption of BBB integrity involving the hippocampus, lateral temporal, and frontal cortices is prominent in 11 month‐old P301S mice. Cell‐specific profiling of early symptomatic 6 month‐old P301S mice identified a defined gene expression profile antecedent to BBB disruption in NVU cells comprised of 29 shared and 3299 unique genes across all cell types. In this early symptomatic stage of tauopathy, pericytes (1021 genes) and astrocytes (1717 genes) were remarkably more transcriptionally active than neurons (561 genes). Gene ontology analysis indicates that multiple molecular programs driving neuronal differentiation, neurite outgrowth, and synaptogenesis are expressed in gliovascular cells in the prodromal stage.Conclusion: The specific and temporally regulated coordination of pathways in pericytes and astrocytes in advance of BBB dysfunction implicates the neurovascular unit as a potential driver in the development of tauopathy. This suggests a paradigm exists for gliovascular rescue of neurodegeneration and implicates numerous novel perivascular molecular pathways in the pathogenesis of tauopathy and Alzheimer’s disease.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S1)
Open AccessMolecular activation of gliovascular signaling precedes blood‐brain barrier disruption and neuronal loss in a mouse model of tauopathy
Background: Increasing evidence points to disruption of the blood‐brain barrier (BBB) as an inciting event in the pathogenesis of Alzheimer’s disease. The contribution of tau‐mediated pathways driving blood‐brain dysfunction are comparatively understudied.Method: Using the P301S mouse model of tauopathy, we employed dynamic contrast enhanced MRI (DCE‐MRI) and quantitative spatial analysis using gadolinium‐based mass spectrometry imaging to demonstrate widespread BBB dysfunction in late stage tauopathy. To identify molecular pathways regulating intercellular signaling between neurons and gliovascular support cells that are dysregulated in advance of BBB disruption, we developed a cell‐specific viral approach for transcriptional profiling of novel pathways within the multicellular environment of the neurovascular unit (NVU) in tauopathy. Viral constructs using cell‐type specific promoters (hSynapsin, GFAP, or PDGFRb) to drive expression of antigen‐tagged ribosomes (TRAP) were used to study variance in spatial and temporal gene expression patterns in NVU cell types in P301S transgenic mice prior to widespread BBB disruption.Result: Regional disruption of BBB integrity involving the hippocampus, lateral temporal, and frontal cortices is prominent in 11 month‐old P301S mice. Cell‐specific profiling of early symptomatic 6 month‐old P301S mice identified a defined gene expression profile antecedent to BBB disruption in NVU cells comprised of 29 shared and 3299 unique genes across all cell types. In this early symptomatic stage of tauopathy, pericytes (1021 genes) and astrocytes (1717 genes) were remarkably more transcriptionally active than neurons (561 genes). Gene ontology analysis indicates that multiple molecular programs driving neuronal differentiation, neurite outgrowth, and synaptogenesis are expressed in gliovascular cells in the prodromal stage.Conclusion: The specific and temporally regulated coordination of pathways in pericytes and astrocytes in advance of BBB dysfunction implicates the neurovascular unit as a potential driver in the development of tauopathy. This suggests a paradigm exists for gliovascular rescue of neurodegeneration and implicates numerous novel perivascular molecular pathways in the pathogenesis of tauopathy and Alzheimer’s disease.
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 244-251
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry
Gadolinium retention in the brain measured with MRI longitudinal relaxation rate mapping and laser ablation inductively coupled plasma mass spectrometry yielded different results, indicating that s... Background T1-weighted MRI and quantitative longitudinal relaxation rate (R1) mapping have been used to evaluate gadolinium retention in the brain after gadolinium-based contrast agent (GBCA) admin...
- 1 January 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 306 (1) , 244-251
Gadolinium Deposition in the Rat Brain Measured with Quantitative MRI versus Elemental Mass Spectrometry
Gadolinium retention in the brain measured with MRI longitudinal relaxation rate mapping and laser ablation inductively coupled plasma mass spectrometry yielded different results, indicating that s... Background T1-weighted MRI and quantitative longitudinal relaxation rate (R1) mapping have been used to evaluate gadolinium retention in the brain after gadolinium-based contrast agent (GBCA) admin...
- 1 February 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (2) , 377-385
Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans
Repeated exposure to intravenous gadopentetate dimeglumine, a linear gadolinium-based contrast agent, is associated with nonhomogeneous retention of gadolinium in rat and human cerebral cortex. Background Gadolinium retention after repeated gadolinium-based contrast agent (GBCA) exposure has been reported in subcortical gray matter. However, gadolinium retention in the cerebral cortex has...
- 1 February 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 294 (2) , 377-385
Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans
Repeated exposure to intravenous gadopentetate dimeglumine, a linear gadolinium-based contrast agent, is associated with nonhomogeneous retention of gadolinium in rat and human cerebral cortex. Background Gadolinium retention after repeated gadolinium-based contrast agent (GBCA) exposure has been reported in subcortical gray matter. However, gadolinium retention in the cerebral cortex has...